These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 23726376)

  • 21. Cognitive and adaptive deficits in young children with Duchenne muscular dystrophy (DMD).
    Cyrulnik SE; Fee RJ; Batchelder A; Kiefel J; Goldstein E; Hinton VJ
    J Int Neuropsychol Soc; 2008 Sep; 14(5):853-61. PubMed ID: 18764980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profile of cognitive function in adults with duchenne muscular dystrophy.
    Ueda Y; Suwazono S; Maedo S; Higuchi I
    Brain Dev; 2017 Mar; 39(3):225-230. PubMed ID: 27825737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy.
    Tian C; Wong BL; Hornung L; Khoury JC; Miller L; Bange J; Rybalsky I; Rutter MM
    Neuromuscul Disord; 2016 Nov; 26(11):760-767. PubMed ID: 27614576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.
    Mayhew A; Cano S; Scott E; Eagle M; Bushby K; Muntoni F;
    Dev Med Child Neurol; 2011 Jun; 53(6):535-42. PubMed ID: 21410696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Children born extremely preterm show significant lower cognitive, language and motor function levels compared with children born at term, as measured by the Bayley-III at 2.5 years.
    Månsson J; Stjernqvist K
    Acta Paediatr; 2014 May; 103(5):504-11. PubMed ID: 24494838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower Extremity Functional Outcome Measures in Duchenne Muscular Dystrophy-A Delphi Survey.
    Senesac CR; Lott DJ; Willcocks RJ; Duong T; Smith BK
    J Neuromuscul Dis; 2019; 6(1):75-83. PubMed ID: 30562905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrical impedance myography in Duchenne muscular dystrophy and healthy controls: A multicenter study of reliability and validity.
    Zaidman CM; Wang LL; Connolly AM; Florence J; Wong BL; Parsons JA; Apkon S; Goyal N; Williams E; Escolar D; Rutkove SB; Bohorquez JL;
    Muscle Nerve; 2015 Oct; 52(4):592-7. PubMed ID: 25702806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Gross Motor Milestones in Duchenne Muscular Dystrophy.
    Norcia G; Lucibello S; Coratti G; Onesimo R; Pede E; Ferrantini G; Brogna C; Cicala G; Carnicella S; Forcina N; Fanelli L; Pane M; Mercuri E
    J Neuromuscul Dis; 2021; 8(4):453-456. PubMed ID: 33935100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of locomotor function in young boys with Duchenne muscular dystrophy.
    Smith RA; Newcombe RG; Sibert JR; Harper PS
    Muscle Nerve; 1991 May; 14(5):462-9. PubMed ID: 1870637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.
    Mazzone E; Vasco G; Sormani MP; Torrente Y; Berardinelli A; Messina S; D'Amico A; Doglio L; Politano L; Cavallaro F; Frosini S; Bello L; Bonfiglio S; Zucchini E; De Sanctis R; Scutifero M; Bianco F; Rossi F; Motta MC; Sacco A; Donati MA; Mongini T; Pini A; Battini R; Pegoraro E; Pane M; Gasperini S; Previtali S; Napolitano S; Martinelli D; Bruno C; Vita G; Comi G; Bertini E; Mercuri E
    Neurology; 2011 Jul; 77(3):250-6. PubMed ID: 21734183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the climbing up and climbing down stairs domain scores on the FES-DMD, the score on the Vignos Scale, age and timed performance of functional activities in boys with Duchenne muscular dystrophy.
    Fernandes LA; Caromano FA; Assis SM; Hukuda ME; Voos MC; Carvalho EV
    Braz J Phys Ther; 2014; 18(6):513-20. PubMed ID: 25590443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
    Smith EC; Conklin LS; Hoffman EP; Clemens PR; Mah JK; Finkel RS; Guglieri M; Tulinius M; Nevo Y; Ryan MM; Webster R; Castro D; Kuntz NL; Kerchner L; Morgenroth LP; Arrieta A; Shimony M; Jaros M; Shale P; Gordish-Dressman H; Hagerty L; Dang UJ; Damsker JM; Schwartz BD; Mengle-Gaw LJ; McDonald CM;
    PLoS Med; 2020 Sep; 17(9):e1003222. PubMed ID: 32956407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy.
    Mazzone E; Martinelli D; Berardinelli A; Messina S; D'Amico A; Vasco G; Main M; Doglio L; Politano L; Cavallaro F; Frosini S; Bello L; Carlesi A; Bonetti AM; Zucchini E; De Sanctis R; Scutifero M; Bianco F; Rossi F; Motta MC; Sacco A; Donati MA; Mongini T; Pini A; Battini R; Pegoraro E; Pane M; Pasquini E; Bruno C; Vita G; de Waure C; Bertini E; Mercuri E
    Neuromuscul Disord; 2010 Nov; 20(11):712-6. PubMed ID: 20634072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy.
    Bendixen RM; Lott DJ; Senesac C; Mathur S; Vandenborne K
    Disabil Rehabil; 2014; 36(22):1918-23. PubMed ID: 24499260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.
    McDonald CM; Henricson EK; Han JJ; Abresch RT; Nicorici A; Elfring GL; Atkinson L; Reha A; Hirawat S; Miller LL
    Muscle Nerve; 2010 Apr; 41(4):500-10. PubMed ID: 19941337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy.
    Lott DJ; Forbes SC; Mathur S; Germain SA; Senesac CR; Lee Sweeney H; Walter GA; Vandenborne K
    Neuromuscul Disord; 2014 Jul; 24(7):574-82. PubMed ID: 24798221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the Feasibility and Reliability of Remotely Delivering and Scoring the North Star Ambulatory Assessment in Ambulant Patients with Duchenne Muscular Dystrophy.
    Emery N; Strachan K; Kulshrestha R; Kuiper JH; Willis T
    Children (Basel); 2022 May; 9(5):. PubMed ID: 35626905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy.
    Yin L; Xie ZY; Xu HY; Zheng SS; Wang ZX; Xiao JX; Yuan Y
    Curr Med Sci; 2019 Feb; 39(1):138-145. PubMed ID: 30868504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between clinical outcome measures and parent proxy reports of health-related quality of life in ambulatory children with Duchenne muscular dystrophy.
    McDonald CM; McDonald DA; Bagley A; Sienko Thomas S; Buckon CE; Henricson E; Nicorici A; Sussman MD
    J Child Neurol; 2010 Sep; 25(9):1130-44. PubMed ID: 20558672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy.
    Connolly AM; Malkus EC; Mendell JR; Flanigan KM; Miller JP; Schierbecker JR; Siener CA; Golumbek PT; Zaidman CM; Mcdonald CM; Johnson L; Nicorici A; Karachunski PI; Day JW; Kelecic JM; Lowes LP; Alfano LN; Darras BT; Kang PB; Quigley J; Pasternak AE; Florence JM;
    Muscle Nerve; 2015 Apr; 51(4):522-32. PubMed ID: 25056178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.